May 11, 2020
Myriad gets FDA approval of myChoice CDx as companion diagnostic for Lynparza
Te U.S. Food and Drug Administration (FDA) approved the myChoice CDx test for use as a companion diagnostic by healthcare professionals to identify certaikn advanced ovarian cancer patients.